Trials / Terminated
TerminatedNCT02765737
Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- MiMedx Group, Inc. · Industry
- Sex
- All
- Age
- 12 Months – 70 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter, prospective, randomized, controlled feasibility trial to determine the safety and effectiveness of Dehydrated Human Amnion Chorion Membrane (dHACM) plus Control as compared to Control alone for the treatment of second degree burns (partial thickness burns) as assessed by time to healing and scarring
Detailed description
Multicenter, prospective, randomized, controlled feasibility trial to determine the safety and effectiveness of Dehydrated Human Amnion Chorion Membrane (dHACM) plus Control as compared to Control alone for the treatment of second degree burns as assessed by time to healing and scarring
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dehydrated Human Amnion/Chorion Membrane | Dehydrated human amnion/chorion membrane (dHACM) product and is regulated as a Human Cells, Tissues and Cellular and Tissue Based Product (HCT/P) under Section 361 of the Public Health Service Act by the Food and Drug Administration (FDA). |
| DEVICE | Mepilex Ag |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2016-05-09
- Last updated
- 2022-05-17
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02765737. Inclusion in this directory is not an endorsement.